Servio H. Ramirez

Servio H. Ramirez

Auto-generated profile, based on publicly available information

Servio H. Ramirez

Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2006 in Journal of Neuroimmune Pharmacology
Verified
Journal Article
Closed access
PDF file
YPYuri Persidsky
Yuri Persidsky
SRServio H. Ramirez
Servio H. Ramirez
JHJames Haorah
James Haorah
GKGeorgette D. Kanmogne
Georgette D. Kanmogne

1 December 2020 in Neurobiology of Disease
Verified
Journal Article
Open access
TBTetyana P. Buzhdygan
Tetyana P. Buzhdygan
BDBrandon J. DeOre
Brandon J. DeOre
ABAbigail Baldwin-Leclair
Abigail Baldwin-Leclair
TBTrent A. Bullock
Trent A. Bullock
HMHannah M. McGary
Hannah M. McGary
SRServio H. Ramirez
Servio H. Ramirez
As researchers across the globe have focused their attention on understanding SARS-CoV-2, the picture that is emerging is that of a virus that has serious effects on the vasculature in multiple organ systems including the cerebral vasculature. Observed effects on the central nervous system include neurological symptoms (headache, nausea, dizziness), fatal microclot formation and in rare cases encephalitis. However, our understanding of how the virus causes these mild to severe neurological symptoms and how the cerebral vasculature is impacted remains unclear. Thus, the results presented in this report explored whether deleterious outcomes from the SARS-CoV-2 viral spike protein on primary human brain microvascular endothelial cells (hBMVECs) could be observed. The spike protein, which plays a key role in receptor recognition, is formed by the S1 subunit containing a receptor binding domain (RBD) and the S2 subunit. First, using postmortem brain tissue, we show that the angiotensin converting enzyme 2 or ACE2 (a known binding target for the SARS-CoV-2 spike protein), is ubiquitously expressed throughout various vessel calibers in the frontal cortex. Moreover, ACE2 expression was upregulated in cases of hypertension and dementia. ACE2 was also detectable in primary hBMVECs maintained under cell culture conditions. Analysis of cell viability revealed that neither the S1, S2 or a truncated form of the S1 containing only the RBD had minimal effects on hBMVEC viability within a 48 h exposure window. Introduction of spike proteins to in vitro models of the blood-brain barrier (BBB) showed significant changes to barrier properties. Key to our findings is the demonstration that S1 promotes loss of barrier integrity in an advanced 3D microfluidic model of the human BBB, a platform that more closely resembles the physiological conditions at this CNS interface. Evidence provided suggests that the SARS-CoV-2 spike proteins trigger a pro-inflammatory response on brain endothelial cells that may contribute to an altered state of BBB function. Together, these results are the first to show the direct impact that the SARS-CoV-2 spike protein could have on brain endothelial cells; thereby offering a plausible explanation for the neurological consequences seen in COVID-19 patients.

1 December 2008 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JHJames Haorah
James Haorah
SRServio H. Ramirez
Servio H. Ramirez
NFNicholas Floreani
Nicholas Floreani
SGSanthi Gorantla
Santhi Gorantla
BMBrenda Morsey
Brenda Morsey
YPYuri Persidsky
Yuri Persidsky

29 November 2006 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
JHJames Haorah
James Haorah
SRServio H. Ramirez
Servio H. Ramirez
KSKathy Schall
Kathy Schall
DSDaniel Smith
Daniel Smith
RPRita Pandya
Rita Pandya
YPYuri Persidsky
Yuri Persidsky
The blood–brain barrier (BBB) formed by brain microvascular endothelial cells (BMVEC) regulates the passage of molecules and leukocytes in and out of the brain. Oxidative stress is a major underlying cause of neurodegenerative and neuroinflammatory disorders and BBB injury associated with them. Using human BMVEC grown on porous membranes covered with basement membrane (BM) matrix (BBB models), we demonstrated that reactive oxygen species (ROS) augmented permeability and monocyte migration across BBB. ROS activated matrix metalloproteinases (MMP‐1, ‐2, and ‐9) and decreased tissue inhibitors of MMPs (TIMP‐1 and ‐2) in a protein tyrosine kinase (PTK)‐dependent manner. Increase in MMPs and PTK activities paralleled degradation of BM protein and enhanced tyrosine phosphorylation of tight junction (TJ) protein. These effects and enhanced permeability/monocyte migration were prevented by inhibitors of MMPs, PTKs, or antioxidant suggesting that oxidative stress caused BBB injury via degradation of BM protein by activated MMPs and by PTK‐mediated TJ protein phosphorylation. These findings point to new therapeutic interventions ameliorating BBB dysfunction in neurological disorders such as stroke or neuroinflammation.

1 February 2008 in The American Journal of Pathology
Verified
Journal Article
Closed access
MYMasaru Yamamoto
Masaru Yamamoto
SRServio H. Ramirez
Servio H. Ramirez
SSShinji Sato
Shinji Sato
TKTomomi Kiyota
Tomomi Kiyota
RCRonald L. Cerny
Ronald L. Cerny
TITsuneya Ikezu
Tsuneya Ikezu

1 September 2016 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
KKKeisuke Kawata
Keisuke Kawata
CLCharles Y. Liu
Charles Y. Liu
SMSteven F. Merkel
Steven F. Merkel
SRServio H. Ramirez
Servio H. Ramirez
RTRyan T. Tierney
Ryan T. Tierney
Dianne LangfordDianne Langford
Dianne Langford